848
Participants
Start Date
December 31, 2011
Primary Completion Date
May 31, 2013
Study Completion Date
May 31, 2013
Ceftaroline
Two consecutive infusions q12h for 5 to 7 days
Ceftriaxone
One dose infusion followed by IV saline placebo infused q24h for 5 to 7 days plus two consecutive saline placebo infusion q24h.
Research Site, Beijing
Research Site, Chengdu
Research Site, Guangzhou
Research Site, Haikou
Research Site, Hangzhou
Research Site, Hefei
Research Site, Jiangyin
Research Site, Nanchang
Research Site, Shanghai
Research Site, Shenyang
Research Site, Shenzhen
Research Site, Shijiazhuang
Research Site, Wuxi
Research Site, Bangalore
Research Site, Calicut
Research Site, Goa
Research Site, Hyderabad
Research Site, Jaipur
Research Site, Lucknow
Research Site, Ludhiana
Research Site, Mysore
Research Site, New Delhi
Research Site, Trivandrum
Research Site, Varanasi
Research Site, Vellore
Research Site, Anyang-si
Research Site, Bucheon-si
Research Site, Cheonan-si
Research Site, Chuncheon
Research Site, Daegu
Research Site, Daejeon
Research Site, Incheon
Research Site, Seoul
Research Site, Suwon
Research Site, Wŏnju
Research Site, Kaohsiung City
Research Site, Keelung
Research Site, Taichung
Research Site, Taipei
Research Site, Can Tho
Research Site, Hanoi
Research Site, Ho Chi Minh City
Research Site, Hochiminh
Lead Sponsor
Collaborators (1)
Forest Laboratories
INDUSTRY
Pfizer
INDUSTRY